Add-Aspirin Trial

Add-Aspirin Trial Add-Asprin trial logo

Add-Aspirin is a large clinical trial taking place in the UK, Republic of Ireland and India. The trial aims to involve 11,000 participants to help find out whether using regular aspirin after treatment of early stage cancer can help stop the cancer coming back (3). Add-Aspirin is open to patients with a number of different cancers including oesophageal cancer and stomach cancer.

There is already data from smaller studies supporting the theory that aspirin can be both safe and useful in the treatment of cancer (4). Add-Aspirin is a much larger international trial designed to further investigate the potential benefits of aspirin. Participants that agree to take part in the study will be randomly chosen to either take daily small doses of aspirin, larger doses of aspirin, or a tablet with no active drug ingredient (called a placebo pill). Neither the patient nor the doctor will know which treatment is being given which helps to make the trial results more reliable.

As a low-cost medicine that is widely available, aspirin could have a huge impact on cancer treatment worldwide. If you are interested in taking part in Add-Aspirin, please talk to your doctor who will be able to consider whether you are suitable for the trial.

3. Coyle C, Cafferty FH, Rowley S, MacKenzie M, Berkman L, Gupta S, et al. ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours. Contemp Clin Trials. 512016. p. 56-64

4. Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C. Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol. 2012;23(6):1403-15.

Latest

Heartburn Cancer UK x Serious Cricket

Heartburn Cancer UK x Serious Cricket “We’re delighted to partner with Heartburn Cancer UK and as the approved clothing supplier to over 1000 cricket clubs in the UK, we have a platform whereby we can help raise awareness of oesophageal cancer within the cricketing community”.
Glynis' Story

Glynis' indigestion issues had plagued her, on and off, since childhood. It wasn't until she reached adulthood that, prompted by other medical issues, she made that life changing appointment and her Barrett's journey started.
Team Vacancy

We have a vacancy for a new Operational Executive – Fundraising. We are looking for a friendly experienced fundraiser to join our team. If you know anyone who might be interested in the role, we’d love to hear from them.
£6.4 million for pioneering Cambridge "Sponge on a string trial"

We are thrilled this week to have heard that millions of pounds in funding has been announced to further develop use of The Cytosponge. This new trial could pave the way for the ‘sponge on a string’ test to be established as a routine screening programme to detect Barrett’s oesophagus.

Persistent heartburn

Heartburn is a burning sensation behind the breast bone, usually caused by acid and/or bile reflux. It is a common symptom - however - if you have suffered from heartburn for more than three weeks and regularly have to take off-the-shelf medicines to relieve it, you should talk to your doctor.
Oesophageal cancer

Oesophageal cancer - Early Symptoms, Causes, Prognosis, Prevalence, Diagnosis and Treatment
Barrett's oesophagus

Barrett’s oesophagus, often known as just Barrett’s, is a condition that affects the lining of the oesophagus. Cancer of the oesophagus is more likely in people who have Barrett’s.
The Cytosponge has arrived in Chelmsford

If you live in Chelmsford and suffer with heartburn you may be eligible to take part in our pilot study using The Cytosponge test in the community. It's quick and simple to perform and could save lives...
Information for those with acid reflux

Simple food and lifestyle tips from our resident dietitian that may help to reduce acid reflux and heartburn symptoms
Giving in memory

Giving in memory of someone special can be a positive way to celebrate their life, as well as being of great comfort to friends and family. Our tribute funds create a lasting memorial to your loved one and are completely personal to you.
LINACRE Trial

The Oxford Clinical Trials Unit are applying for funding for an exciting new clinical trial for patients with Barrett’s Oesophagus. Recruited patients will be randomly selected to either continue with life long medication or have a device, called a LINX, fitted at the base of the oesophagus to reduce the symptoms associated with Barrett's.
Basingstoke Support Group

Welcome to the homepage of the Barrett's, Stomach and Oesophageal Cancer support group based in Basingstoke, Hampshire.
Newsletters

Please take a look at our current and historic newsletters
Danny's Story

Danny lost his short battle with oesophageal cancer on the 21st February 2021. His family want to share his story to encourage others to seek medical advice if they have any health concerns.